EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Recent Advances (2020–2025) in Estrogen and ER-Positive Breast Cancer: Receptor Signaling, Tumor Microenvironment, Endocrine Therapy Resistance and Innovative Treatment Strategies—A Comprehensive Review

Jiaxin Zhao iD, Donghai Li, Shaofeng Yang, Xin Ma

Cancer Management and Research · 2026-08 · Volume 18 · 1-23

DOI: 10.2147/cmar.s622575 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Management and Research, 2026-08. Verfasst von Jiaxin Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid Breast Surgery, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010050, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

TMEbreast cancerdrug resistanceendocrine therapyestrogenestrogen receptor

Autor:innen und Institutionen

  • Department of Thyroid Breast Surgery, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010050, People's Republic of China.

ORCID-Profile: Jiaxin Zhao

Zitieren

APA

Zhao, J., Li, D., Yang, S., & Ma, X. (2026). Recent Advances (2020–2025) in Estrogen and ER-Positive Breast Cancer: Receptor Signaling, Tumor Microenvironment, Endocrine Therapy Resistance and Innovative Treatment Strategies—A Comprehensive Review. Cancer Management and Research, Volume 18, 1-23. https://doi.org/10.2147/cmar.s622575

Vancouver

Zhao J, Li D, Yang S, Ma X. Recent Advances (2020–2025) in Estrogen and ER-Positive Breast Cancer: Receptor Signaling, Tumor Microenvironment, Endocrine Therapy Resistance and Innovative Treatment Strategies—A Comprehensive Review. Cancer Management and Research. 2026;Volume 18:1-23. doi:10.2147/cmar.s622575

BibTeX
@article{Zhao2026,
  author = {Zhao, Jiaxin and Li, Donghai and Yang, Shaofeng and Ma, Xin},
  title = {Recent Advances (2020–2025) in Estrogen and ER-Positive Breast Cancer: Receptor Signaling, Tumor Microenvironment, Endocrine Therapy Resistance and Innovative Treatment Strategies—A Comprehensive Review},
  journal = {Cancer Management and Research},
  year = {2026},
  volume = {Volume 18},
  pages = {1--23},
  doi = {10.2147/cmar.s622575}
}
Kostenlos starten →